Program Director and Faculty Information

Where You Are:

Program Director

Kenneth S. Zuckerman, MD - Clinical: Myeloproliferative neoplasms, benign hematology; Research: Stem cell biology, hematopoiesis; leukemia signal transduction

Moffitt Cancer Center Hematology/Medical Oncology Faculty

Khaldoun Almhanna, MD, MPH – Clinical: Gastrointestinal malignancies, specifically esophageal and gastric cancer; Research: Phase I/II trials in Gastrointestinal cancers, specifically esophageal and gastric cancer focusing on personalized targeted therapy.

Scott J. Antonia, MD, PhD - Clinical: Thoracic oncology; Research: Immune recognition, cancer vaccines, and immunotherapy

Lodovico Balducci, MD – Clinical: Senior Adult Oncology; Research: clinical aspects of cancer in geriatric patients

Rachid Baz, MD – Clinical: Plasma cell dyscrasias, multiple myeloma; Research: Malignant hematology phase I and II clinical trials

Celeste Bello, MD – Clinical: Clinically focused towards the treatment of non-Hodgkin's and Hodgkin's lymphomas; Research: Primarily directed toward the clinical evaluation of novel therapies in the treatment of Hodgkin's and non-Hodgkin's lymphoma

Paul A. Chervenick, MD – Clinical: Malignant and benign hematologic disorders; Research: Role of hematopoietic growth factors on stem cell proliferation and differentiation; Leukemia & Lymphoma

Alberto A. Chiappori, MD - Clinical: Lung Cancer; Research: Clinical trials in advanced Non-Small Cell Lung Cancer

Ronald C. DeConti, MD - Clinical: Melanoma and head and neck cancer; Research: Clinical trials for the treatment of melanoma and head and neck cancers

William R. Dinwoodie, MD - Clinical: Colorectal cancer, gastro-esophageal cancer, biliary tract cancer; Research: Clinical trials in colon, pancreatic, and gastric and esophageal cancers

Martine Extermann, MD, PhD - Clinical: Senior Adult Oncology; Research: Clinical factors and co-morbidities that affect outcomes in elderly patients with cancer

Mayer Fishman, MD, PhD - Clinical: Early phase clinical trials, with emphasis on metastatic kidney cancer and novel agents; Research: Determinants of response to immune therapy of genitourinary cancers; Phase I and II clinical trials in genitourinary cancers

Jhanelle Gray, MD - Clinical: Thoracic oncology; Research: Chemoprevention of lung cancer and the targeting of treatment based on genetics in lung cancer patients

Shilpa Gupta, MD - Clinical: Prostate, Bladder, Kidney and Testicular cancer; Research: Developing early phase clinical trials using novel targeted agents for genitourinary cancers with an emphasis on prostate and bladder cancer.

Heather S. Han, MD - Clinical: Breast cancer; Research: Preoperative therapy in breast cancer and racial disparities and breast cancer

Eric B. Haura, MD - Clinical: Lung Cancer, Non-small cell lung cancer, novel signal tranduction inhibitors for the treatment of lung cancer and special interest in management of lifelong non-smokers with lung cancer; Research: Understanding the role of tyrosine kinase and STAT signaling in lung cancer and special interest in management of lifelong non-smokers with lung cancer.

Roohi Ismail-Khan, MD - Clinical: Breast Cancer; Research: Clinical trials in triple-negative (ER negative, PR negative, HER 2 negative) breast cancer

Richard Kim, MD - Clinical: Gastrointestinal oncology, hepatocellular carcinoma; Research: Phase I and II clinical trials in hepatocellular carcinoma and other GI malignancies

Julie A. Kish, MD, FACP - Clinical: Head & Neck and genitourinary cancers; Research: Clinical trials in Head & Neck and GU cancers

Rami S. Komrokji, MD - Clinical: Myelodysplastic syndromes (MDS), Acute Myeloid leukemia (AML), Non-Hodgkin's Lymphoma, Hodgkin's Disease; Research: Phase I and II clinical trials in Hematologic Malignancies with a focus on Myelodysplastic syndromes and acute myeloid leukemia

Ragini Kudchadkar, MD - Clinical: Immunotherapy of melanoma and other malignancies; Research: Clinical trials in patients with metastatic melanoma

Jeffrey E. Lancet, MD - Clinical: Acute and chronic leukemias, as well as myelodysplastic syndromes; Research: Early phase clinical trials for refractory leukemias, Signal transduction inhibitors in hematologic malignancies and autologous hematopoietic cell transplantation in AML

Alan F. List, MD - Clinical: Myelodysplastic syndromes (MDS), Acute myeloid leukemia (AML), and myeloproliferative disorders (MPD); Research: Development of novel therapeutics for acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS)

Loretta S. Loftus, MD - Clinical: Breast Cancer; Research: Breast cancer risk reduction and prevention, ductal carcinoma in situ of the breast and bisphosphanate therapy in breast cancer

Susan E. Minton, DO - Clinical: Treatment for neoadjuvant and metastatic breast cancer; Research: Translational research investigating novel molecular markers for breast cancer. Clinical translational neoadjuvant treatment trials for high-risk breast cancer

Eric Padron, MD - Clinical: Adult myeloid malignancies including MDS, AML and Myeloproliferative Neoplasms (MPNs) with a specific interest in Myeloproliferative/Myelodysplastic (MDS/MPN) syndromes; Research: Develop novel targeted approaches for patients with AML, CMML and MDS

Mary C. Pinder-Schenck, MD - Clinical: Thoracic malignancies and interest in the care of women in lung cancer. Research: Clinical trials of novel agents and combinations for patients with thoracic malignancies

Javier Pinilla-Ibarz, MD, PhD - Clinical: Leukemias and myelodysplastic syndromes (MDS) with special interest in chronic myeloid leukemia (CML) and chronic lymphocytic leukemia (CLL); Research: Implementing new immunotherapeutic strategies in the field of malignant hematology

Bijal D. Shah, MD - Clinical: Hematologic malignancies, with an emphasis on lymphomas; Research: Clinical trials and factors that affect outcomes in mantle cell lymphomas.

Kenneth H. Shain, MD, PhD - Clinical: Multiple myeloma; Research: Basic research on cell-microenvironmental influences and mechanisms of chemotherapy resistance in myeloma cells; clinical trials in multiple myeloma.

Lubomir Sokol, MD, PhD - Clinical: T/NK cell lymphomas/Leukemias, Polycythemia, Myelodysplastic syndromes; Research: miRNA microarray profiling of MDS, molecular pathogenesis of Large granular lymphocyte leukemia and molecular pathogenesis of polycythemias

Hatem Soliman, MD - Clinical: Breast cancer; Research: Development of new immunotherapy (vaccines, immune modulating drugs) in the treatment of breast cancer

Eduardo M. Sotomayor, MD - Clinical: Mantle Cell Lymphoma (MCL), other lymphomas; Research: Immunotherapy of B-cell malignancies, with special emphasis in the design of novel cancer vaccines and monoclonal antibodies; Phase I and II clinical trial for patients with mantle cell lymphoma

Gregory M. Springett, MD, PhD - Clinical: Pancreatic cancer; Research: Investigating the role of Rap1 (a small G-protein that is a close relative of H-ras) in human malignancies; clinical trials in pancreatic cancer

Jonathan R. Strosberg, MD - Clinical: Neuroendorine malignancies, specifically carcinoid tumors and pancreatic endocrine (islet cell) tumors; Research: Phase 2 trials in neuroendocrine cancers, specifically carcinoid and pancreatic endocrine tumors, focusing on biologic targeted therapy

Tawee Tanvetyanon, MD - Clinical: Thoracic malignancies (lung cancer, mesothelioma, thymoma) and cancers of the head and neck; Research: Clinical trials in lung cancer

Jeffrey S. Weber, MD, PhD - Clinical: Immunotherapy of melanoma and other malignancies, with a focus on vaccines, adoptive immunotherapy, dendritic cell therapy and the use of immune modulating antibodies; Research: Monitoring and characterization of T cell responses to vaccination in cancer patients, and in the establishment of in vitro models to facilitate the understanding of how immune modulating antibodies amplify T cell responses in patients; Clinical trials in melanoma

Charles C. Williams, Jr, MD - Clinical: Lung cancer; Research: Clinical trials in lung cancer

Jingsong Zhang, MD, PhD - Clinical: Prostate cancer; Research: Identifying and then targeting the DNA damage repair pathways in metastatic prostate cancer; developing new treatments and markers for prostate cancer

James A. Haley Veterans’ Hospital Hematology/Medical Oncology Faculty

John Accomando, MD -

Maria Bazzini, DO -

Donald Doll, MD -

Terrence Grady, MD -

Dipali Trivedi, MD

University of South Florida, College of Medicine, Hematology/Medical Oncology Faculty

Benjamin Djulbegovic, MD, PhD - Clinical: Hematologic malignancies; Research: Hematologic malignancies, research-synthesis, decision-analysis, role of uncertainty in medicine, evidence-based medicine, methodology and ethics of clinical trials

Hussain I. Saba, MD, PhD - Clinical: Myelodysplastic syndrome; acute and chronic leukemias, non-Hodgkin lymphomas; hemostasis; hemophilia & Von Willebrand disease; thrombosis; Research: Myelodysplastic syndrome; acute and chronic leukemias, non-Hodgkin lymphomas; hemostasis; hemophilia & Von Willebrand disease


Hematology | Medical Oncology
Application Process and Deadlines 
Clinical Training 
Contact Information
Core Requirements 
Education | Conferences 
Number of positions 
Program Director & Faculty Information 
Tampa Bay
Training Sites

TOOLS:   Font Size small font resizer separator font resizer separator big font resizer
 |  Site Map  |  Privacy Policy  |  Terms and Conditions